evan yu, md, on combining checkpoint inhibitors in metastatic castration-resistant prostate cancer
Published 5 years ago • 101 plays • Length 1:29
Download video MP4
Download video MP3
Similar videos
-
4:41
immunotherapy's role in prostate cancer | evan yu, md & mark moyad, md, mph | pcri 2020
-
2:18
evan yu, md, regarding combination pembrolizumab and olaparib in mcrpc
-
50:29
treatments for advanced prostate cancer in 2022 | evan yu, md | pcri
-
1:10
dr. yu on the future of castration-sensitive prostate cancer
-
46:19
binaytara foundation_ dr. evan yu's talk on metastatic prostate cancer
-
2:28
dr. yu on treatment intensification in metastatic castration-sensitive prostate cancer
-
1:06
dr. yu on comorbidities and therapy choice in prostate cancer
-
6:34
asco22 prostate cancer updates | evan yu, md | seattle cancer care alliance
-
4:55
3 future prostate cancer treatment advancements | mark scholz, md & mark moyad, md | 2021 pcri
-
10:14
dr. yu's detoxification protocol
-
3:25
life expectancy with prostate cancer diagnosis
-
5:39
early treatment intensification for mcspc: optimising patient selection and treatment
-
1:09
dr. yu on the utility of pet imaging in prostate cancer
-
1:54
dr. yu on the significance of the protect study in prostate cancer
-
8:15
introduction and overview of castration-resistant prostate cancer treatment challenges
-
3:00
dutreneo trial
-
1:28
dr. yu on trials of moderate hypofractionation in prostate cancer
-
1:42
dr. yu compares treatment options for prostate cancer
-
34:34
active surveillance of prostate cancer with yushen qian, md
-
2:33
dr. yu on novel pet imaging in prostate cancer
-
1:17
dr. yu discusses observation versus treatment in men with prostate cancer
Clip.africa.com - Privacy-policy